Studies on MabThera delivery method positive

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Dec, 2012

Singapore: Two studies by Roche has demonstrated that a fixed dose of MabThera (rituximab) can be administered subcutaneously, potentially allowing patients to spend less time at infusion c...Read more

Merck to develop processes for stem cell cultures

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2012

Singapore: Merck Millipore, the life science division of Merck, and the Institute of Bioprocess Engineering and Pharmaceutical Technology, Mittelhessen University of Applied Sciences have c...Read more

Scientists find cellular origin of cervical cancer

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jun, 2012

Singapore: A team of scientists from A*STAR's Institute of Medical Biology (IMB) and Genome Institute of Singapore (GIS), together with clinicians from Boston's Brigham and Women's Hospital...Read more

Analytical instruments market to soar in China

Biologics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 26 Nov, 2012

Singapore: China is soon expected to become a sales hub for lab analytical instruments as international companies speed up localized manufacturing in tandem with the country's economic grow...Read more

China Biologic to report Q2 results

Biologics |  Company results | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, will release its second quarter 2013 financial results on Tuesday, August 6, ...Read more

Oncotest, Debiopharm identify biomarker candidates

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Apr, 2013

Singapore: Germany-based Oncotest and Debiopharm, a Swiss-based global biopharmaceutical group, have completed first biomarker projects at Oncotest. The pharmacological data was generated ...Read more

EMA recommends MSD's melanoma drug

Biologics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 27 May, 2015

Singapore: European Medicines Agency (EMA) has recommended granting a marketing authorization for Merck Sharp And Dohme's Keytruda (pembrolizumab) as monotherapy for the treatment of adult ...Read more

Intrexon appoints new VP and CIO

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Nov, 2013

Singapore: US-based Intrexon, a synthetic biology company, has appointed Dr Peter Seufer-Wasserthal as VP, business development for Europe and Asia and Ms Dana Di Ferdinando as chief inform...Read more

China Biologic clocks sales of $53.6 mn

Biologics |  Company results | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2013

Singapore: China Biologic Products reported its unaudited financial results for the second quarter of 2013. Total sales in the second quarter of 2013 increased by 6.2 percent to $53.6 milli...Read more

China Biologic reports 21.1% growth in sales revenue

Biologics |  Company results | By BioSpectrum Bureau  | 0 Comment | 10 Aug, 2012

Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, announced its unaudited financial results for the second quarter of 2012. Tot...Read more

GE launches new software for molecular screening

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

Singapore: GE Healthcare has launched Biacore T200 Software v.2.0, offering researchers a flexible and powerful tool for efficient processing of molecular interaction data. It facilitates ...Read more

Biochips firm AyoxxA gets $3.37 million funding

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Sep, 2012

Singapore: AyoxxA Biosystems, an international biotechnology company, has closed a $3.37 million (2.6 million Euro) series A financing round. The round was led by Wellington Partners Ventur...Read more

China's JHL Biotech raises $35 million

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jun, 2014

Singapore: China based emerging biopharmaceutical company, JHL Biotech, has closed a Series B financing round of $35 million, funded by Milestone Capital and a consortium of Taiwan venture ...Read more

bioCSL inks a deal with Immucor

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jul, 2014

Singapore: BioCSL has inked a deal with US-based Immucor to distribute transfusion testing technology in Australia and New Zealand. BioCSL has already started distribution of Immucor's capt...Read more

Promega opens new facility in Shanghai

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

Singapore: Promega opened a new facility in Shanghai for its China operations. The new site for Shanghai Promega Biological Products replaces an existing molecular biology reagent productio...Read more

Novel protein complex to combat gastric cancer

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2014

Singapore: A team of scientists from Cancer Science Institute of Singapore (CSI) at National University of Singapore (NUS) have discovered  a protein named IL23A as part of human stomach's...Read more

China Biologic names David Gao as CEO

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

Singapore: China Biologic Products, one of the leading plasma-based biopharmaceutical companies in China, has appointed Chairman David (Xiaoying) Gao to the additional position of chief exe...Read more

Shimadzu launches smart device enabled HPLC system

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2014

Singapore: Japan-based global analytics technology provider, Shimadzu, has launched i-Series of new industry standard HPLCs (High Performance Liquid Chromatograph) systems, with built-in to...Read more